Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology UnitNCT07158463
Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit of Sohag University Hospital
An observational study of Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit, run by Sohag University at 1 site in Egypt.
Trial summary
Plasmapheresis also known as a therapeutic plasma exchange (TPE) TPE is an extracorporeal blood purification technique designed for the removal of large-molecular-weight substances. Read more about this study
- Who is it for?
- Ages 1 year to 18 years
- Conditions the study is for
- Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit
- How many people
- 25 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Aug 2025to 15 Aug 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: All pediatric patients (aged 1-18 years) who underwent TPE during the study period. Both male and female.
Who may be able to join
- All pediatric patients (aged 1-18 years) who underwent TPE during the study period.
- Both male and female.
Who cannot join
- Patients who cannot tolerate central line placement Patients who are in an actively septic state or are hemodynamically unstable . Patients who have allergies to fresh frozen plasma (FFP) or albumin, depending on the type of plasma exchange
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Shohanda Ahmed Mohamed, Master degree contact
About this study
Plasmapheresis also known as a therapeutic plasma exchange (TPE) TPE is an extracorporeal blood purification technique designed for the removal of large-molecular-weight substances. Examples of these substances include pathogenic autoantibodies, immune complexes, cryoglobulins, myeloma light chains, endotoxin, and cholesterol-containing lipoproteins Document the indications, procedures, outcomes, and complications associated with TPE in pediatric patients at Sohag University Hospital.
To compare our findings with existing national and international data to identify areas for improvement and standardization.
To evaluate the safety and efficacy of TPE in our pediatric nephrology unit.
What is being measured
The primary outcome is the main question the study is designed to answer.
Efficacy of therapeutic plasma exchange in pediatric nephrology unit
Measured: One month after last session
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Sep 2025
- Study start15 Aug 2025
- Primary completion1 Aug 2026 (estimated)
- Study completion15 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology UnitStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 25 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shohanda Ahmed Mohamed, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07158463
- Sponsor's protocol ID
- Soh-Med--25-8-7MS
- Status last verified
- Aug 2025
- First submitted
- 28 Aug 2025
- Last updated
- 5 Sep 2025
- Results posted
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 5 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit of Sohag University Hospital
- ClinicalTrials.gov ID
- NCT07158463
- Acronym / sponsor ID
- Soh-Med--25-8-7MS
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 25 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 15 Aug 2025 (actual)
- Primary completion
- 1 Aug 2026 (estimated)
- Study completion
- 15 Aug 2026 (estimated)
- First posted
- 5 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Plasmapheresis also known as a therapeutic plasma exchange (TPE) TPE is an extracorporeal blood purification technique designed for the removal of large-molecular-weight substances. Examples of these substances include pathogenic autoantibodies, immune complexes, cryoglobulins, myeloma light chains, endotoxin, and cholesterol-containing lipoproteins Document the indications, procedures, outcomes, and complications associated with TPE in pediatric patients at Sohag University Hospital.
To compare our findings with existing national and international data to identify areas for improvement and standardization.
To evaluate the safety and efficacy of TPE in our pediatric nephrology unit.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 1 year to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- All pediatric patients (aged 1-18 years) who underwent TPE during the study period. Both male and female.
Key inclusion criteria (2 listed)
- All pediatric patients (aged 1-18 years) who underwent TPE during the study period.
- Both male and female.
Key exclusion criteria (1 listed)
- Patients who cannot tolerate central line placement Patients who are in an actively septic state or are hemodynamically unstable . Patients who have allergies to fresh frozen plasma (FFP) or albumin, depending on the type of plasma exchange
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Efficacy of therapeutic plasma exchange in pediatric nephrology unit
Time frame: One month after last session
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Sep 2025.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Shohanda Ahmed Mohamed, Master degree contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Shohanda Ahmed Mohamed, Master degree (01228288470 ext. 01112966126, shohandaahmed12345@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Efficacy of therapeutic plasma exchange in pediatric nephrology unit (time frame: One month after last session). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2025.